‘More Promising Mesothelioma Clinical Trials than Ever Before,’ Says Expert
PR Web |
During the
In her talk, she mentioned several trials that have been reporting increased survival and response rates. Some include novel radiation treatments, while the focus of others is within the field of immunotherapy. One trial, in particular, is looking very promising with a 69% durable response in a small group of patients. Ms. Hesdorffer stated that a new, larger trial currently underway is looking to confirm these results.
"A clinical trial is a unique opportunity for a patient to try something new and innovative that could have a very positive impact on the patient's disease," said Ms. Hesdorffer. "Having options is an important step forward in a disease that merely a decade ago was seen as hopeless," she added.
Ms. Hesdorffer provides free consultations about clinical trials, as well as other issues pertaining to mesothelioma, as part of the
"While healthcare providers aren't able to review all clinical trial options with their patients due to time constrains, at the
<person>Mary Hesdorffer, MS, APRN-BC, is a nurse practitioner with over 16 years of experience in mesothelioma treatment. She is an expert in clinical trials for mesothelioma and her work has been published in a variety of scientific journals.
Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. Medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the
About the
###
Read the full story at http://www.prweb.com/releases/2014/08/prweb12062719.htm
Copyright: | (c) 2014 PRWEB.COM Newswire |
Wordcount: | 481 |
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News